IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Return on equity 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-56.0%FY2025 · since FY2016: -31.7% → -56.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -56.0% | -3.6 pp |
| FY2024 | -52.4% | +23.6 pp |
| FY2023 | -75.9% | — |
| FY2018 | -26.5% | +36.8 pp |
| FY2017 | -63.3% | -31.6 pp |
| FY2016 | -31.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice